Facebook
Twitter
LinkedIn

FAST Company

Avro Life Science

Contact
founders@avrolifesci.com

Website
https://www.avrolifesci.com/

Avro Life Science has developed a novel material for transdermal drug delivery of multiple small molecule drugs, across a wide range of therapeutic categories including cardiovascular health, neuroscience, diabetes, consumer health, and more.

The patches are currently capable of delivering drugs consistently over a 24 hour period, and are in the late stages of R&D for 3 day or 72 hour patches, to increase convenience and compliance among patient populations and provide a steady delivery profile of therapeutics over an extended time period.